Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
27.35
+0.02 (0.07%)
Jul 24, 2026, 4:00 PM EDT - Market closed
Arcutis Biotherapeutics Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, Arcutis Biotherapeutics stock has a consensus rating of "Buy" and an average price target of $34.63. The average 1-year stock price forecast is 26.62% higher than the current stock price, while the lowest is $33 (+20.66%) and the highest is $36 (+31.63%).
Price Target: $34.63 (+26.62%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Arcutis Biotherapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 8 | 8 | 8 | 8 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Guggenheim | Guggenheim | Buy Reiterates $35 | Buy | Reiterates | $35 | +27.97% | Jul 17, 2026 |
| Mizuho Securities | Mizuho Securities | Buy Reiterates $35 | Buy | Reiterates | $35 | +27.97% | Jul 15, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $35 | Buy | Maintains | $35 | +27.97% | Jul 9, 2026 |
| Needham | Needham | Buy Maintains $36 | Buy | Maintains | $36 | +31.63% | Jun 30, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $34 | Buy | Reiterates | $34 | +24.31% | May 11, 2026 |
Financial Forecast
Revenue This Year
500.09M
from 376.07M
Increased by 32.98%
Revenue Next Year
647.23M
from 500.09M
Increased by 29.42%
EPS This Year
0.18
from -0.13
EPS Next Year
1.13
from 0.18
Increased by 541.50%
EPS and Forward PE are based on non-GAAP adjusted numbers.